Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Waldenstrom Macroglobulinemia 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Promyelocytic, Acute 1Leukemia, Prolymphocytic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Endometrial Neoplasms 1

Interventions

Early Intervention, Educational 9Indocyanine Green 8Surveys and Questionnaires 7Methods 7Counseling 7Blood Specimen Collection 6Sentinel Lymph Node Biopsy 5Lymph Node Excision 5Exercise 5Robotic Surgical Procedures 4Radiotherapy 4Genetic Testing 4Radiation Dose Hypofractionation 3Radiation 3Psychiatric Rehabilitation 3Paclitaxel 3Motivational Interviewing 3Educational Status 3Diet 3Behavior Therapy 3iso-sulfan blue 2Videotape Recording 2Trehalase 2Therapeutics 2Surgical Procedures, Operative 2Standard of Care 2Palliative Care 2Megestrol Acetate 2Laparoscopy 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Endometrial Neoplasms × Arsenic Trioxide × Clear all
NCT04489706 2020-07-28

Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation

Ruijin Hospital

Phase NA Unknown
20 enrolled
Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡